Literature DB >> 24329567

Continuous renal replacement therapy reduces the systemic and pulmonary inflammation induced by venovenous extracorporeal membrane oxygenation in a porcine model.

Jialiang Shi1, Qiyi Chen, Wenkui Yu, Juanhong Shen, Jianfeng Gong, Changsheng He, Yiming Hu, Juanjuan Zhang, Tao Gao, Fengchan Xi, Jieshou Li.   

Abstract

Pulmonary changes in veno-venous extracorporeal membrane oxygenation (VV-ECMO) are rarely determined. We compared the contribution of VV-ECMO and cannulation based on the observation of pulmonary inflammatory reaction and parenchymal construction in a porcine model of low tidal volume (VT ) ventilation. We also evaluated the effect of adding continuous renal replacement therapy (CRRT) to the ECMO circuit, because CRRT is known to reduce systemic cytokine release induced by VV-ECMO. A total of 18 pigs undergoing low-VT ventilation were randomly divided into three groups (group 1, cannulation; group 2, VV-ECMO; group 3, VV-ECMO + CRRT) and studied for 24 h. Hemodynamic and ventilation parameters were recorded. We assessed plasma and alveolar cytokines, expression of pulmonary inflammatory genes, histopathological grading, and ultrastructural changes of the lungs. During the process, inspiratory volume increased and PaO2 decreased in group 1. Systemic tumor necrosis factor-α (TNF-α) and interleukin 6 (IL-6) levels increased at 2 h in group 2 and partly decreased in group 3. At 24 h, the levels of bronchoalveolar lavage fluid, TNF-α, and IL-6 in group 2 were remarkably higher than those in groups 1 and 3. Pulmonary mRNA expression of cytokines did not differ between the groups. We observed an increased score of pulmonary pathological findings in pro-inflammatory cell infiltration and interstitial thickening of the lungs in group 2. The epithelium of the blood-air barrier after VV-ECMO was swollen. In group 3, the pulmonary parenchyma and blood-air barrier were well preserved. We concluded that in a porcine model of low-VT ventilation, both VV-ECMO and VV-ECMO in combination with CRRT provided adequate oxygenation and carbon dioxide removal. Compared with VV-ECMO alone, VV-ECMO in combination with CRRT better preserved the lung parenchyma by eliminating systemic cytokines.
© 2013 Wiley Periodicals, Inc. and International Center for Artificial Organs and Transplantation.

Entities:  

Keywords:  Continuous renal replacement therapy; Cytokine; Electron microscopy; Extracorporeal membrane oxygenation; Histopathology; Lung

Mesh:

Substances:

Year:  2013        PMID: 24329567     DOI: 10.1111/aor.12154

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  16 in total

1.  Continuous renal replacement therapy with a polymethyl methacrylate membrane hemofilter suppresses inflammation in patients after open-heart surgery with cardiopulmonary bypass.

Authors:  Hiroshi Mukaida; Satoshi Matsushita; Takahiro Inotani; Atsushi Nakamura; Atsushi Amano
Journal:  J Artif Organs       Date:  2018-02-05       Impact factor: 1.731

Review 2.  COVID-19 and Extracorporeal Membrane Oxygenation.

Authors:  Gennaro Martucci; Artur Słomka; Steven Eric Lebowitz; Giuseppe Maria Raffa; Pietro Giorgio Malvindi; Valeria Lo Coco; Justyna Swol; Ewa Żekanowska; Roberto Lorusso; Waldemar Wierzba; Piotr Suwalski; Mariusz Kowalewski
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  The successful use of extracorporeal membrane oxygenation combined with continuous renal replacement therapy for a cardiac arrest patient with refractory hypokalemia and diabetic ketoacidosis.

Authors:  Yang Li; Rui Xu; Chun-Shui Cao; Liang Huang
Journal:  World J Emerg Med       Date:  2022

4.  COVID-19, ECMO, and lymphopenia: a word of caution.

Authors:  Brandon Michael Henry
Journal:  Lancet Respir Med       Date:  2020-03-13       Impact factor: 30.700

Review 5.  Kidney-lung connections in acute and chronic diseases: current perspectives.

Authors:  Luca Visconti; Domenico Santoro; Valeria Cernaro; Michele Buemi; Antonio Lacquaniti
Journal:  J Nephrol       Date:  2016-03-03       Impact factor: 3.902

6.  Venovenous Extracorporeal Membrane Oxygenation for Postoperative Acute Respiratory Distress Syndrome.

Authors:  Dong Ju Seo; Jae Suk Yoo; Joon Bum Kim; Sung-Ho Jung; Suk Jung Choo; Cheol Hyun Chung; Jae Won Lee
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2015-06-05

7.  Continuous renal replacement therapy in children with severe sepsis and multiorgan dysfunction - A pilot study on timing of initiation.

Authors:  Krishna Mohan Gulla; Anil Sachdev; Dhiren Gupta; Neeraj Gupta; Kanav Anand; P K Pruthi
Journal:  Indian J Crit Care Med       Date:  2015-10

8.  Severe ARDS caused by adenovirus: early initiation of ECMO plus continuous renal replacement therapy.

Authors:  Sang Ook Ha; Hyoung Soo Kim; Sunghoon Park; Ki-Suck Jung; Seung Hun Jang; Sang Jin Han; Hyun-Sook Kim; Sun Hee Lee
Journal:  Springerplus       Date:  2016-11-03

Review 9.  The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology.

Authors:  Jonathan E Millar; Jonathon P Fanning; Charles I McDonald; Daniel F McAuley; John F Fraser
Journal:  Crit Care       Date:  2016-11-28       Impact factor: 9.097

10.  Monitoring lung injury with particle flow rate in LPS- and COVID-19-induced ARDS.

Authors:  Martin Stenlo; Iran A N Silva; Snejana Hyllén; Deniz A Bölükbas; Anna Niroomand; Edgars Grins; Per Ederoth; Oskar Hallgren; Leif Pierre; Darcy E Wagner; Sandra Lindstedt
Journal:  Physiol Rep       Date:  2021-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.